Clinical Trials
2 trialsNCT01468896 2026-04-29
Cetuximab and Recombinant Interleukin-12 in Treating Patients With Squamous Cell Carcinoma of the Head and Neck That is Recurrent, Metastatic, or Cannot Be Removed by Surgery
National Cancer Institute (NCI)
Phase 1/2 Active not recruiting
NCT00622401 2017-11-14
Vaccination of Patients With Breast Cancer With Dendritic Cell/Tumor Fusions and IL-12
Dana-Farber Cancer Institute
Phase 1/2 Terminated